Journal list Promote Sponsor
verified SJR 3,577 · Q1 • database Scopus / SJR & Web of Science indexed
Trends in Molecular Medicine
United Kingdom · Elsevier Ltd
workspace_premium Q1 — Molecular Biology lock_open Open Access

Trends in Molecular Medicine

Trends in Molecular Medicine is a journal indexed in SJR in Molecular Biology and Molecular Medicine with an H index of 213. It has an SJR impact factor of 3,577 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,577.

Trends in Molecular Medicine focuses its scope in these topics and keywords: contribution, clinical, diabetes, emerging, gabaergic, aneurysmssensing, cardiometabolic, identification, genomicsbased, erythematosus, ...

ISSN: 1471-4914
Publisher: Elsevier Ltd
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
3,577 Q1
H-index 213
Acceptance rate pie_chart
20% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

3,577

H-index

213

Docs (year)

151

Docs 3y

334

Total refs

9553

Cites 3y

3225

Citable 3y

302

Cites/Doc 2y

9.61

Ref/Doc

63.26

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cell fusion and reprogramming: resolving our transdifferences

View more

Who owns your body? Legal issues on the ownership of bodily material

View more

Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases

View more

Epigenetics is alive and growing

View more

Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine

View more

Drugs in the postgenomic era

View more

Disease model: Parkinson's disease

View more

DiGeorge modifiers

View more

Deconstructing dementia

View more

Cystic fibrosis gene therapy trials and tribulations

View more

Cord blood: from waste product to valuable resource

View more

Controlling hepatitis C

View more
SHOW MORE ARTICLES

Co-stimulation agonists as a new immunotherapy for autoimmune diseases

View more

A bit like Brighton Pier. Management of Genetic Syndromes

View more

Cancer Research UK looks to NCI forsuccess

View more

Calpains: targets of cataract prevention?

View more

Building bone

View more

Breakthrough in HIV dementia

View more

Brain targeting through the autonomous nervous system: lessons from prion diseases

View more

Blood thirsty

View more

Association of PADI4 and rheumatoid arthritis: a successful multidisciplinary approach

View more

Antigen sampling by mucosal dendritic cells

View more

Antibody-directed therapies for hematological malignancies

View more

Adventures in genetics: Abraham Lincoln's DNA and other Adventures in Genetics

View more

FAQs